SCHEMBL4356364

SCHEMBL4356364

C#Cc1cccc(Nc2ncnc3cc4ccccc4cc23)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.69
FBP1 P09467 3/20 0.69
GAK O14976 3/20 0.69
ALDH1A1 P00352 1/20 0.69
MAPT P10636 1/20 0.69
RIPK2 O43353 2/20 0.64
BUB1 O43683 2/20 0.64
STK10 O94804 2/20 0.64
MAP3K1 Q13233 2/20 0.64
PIP4K2C Q8TBX8 2/20 0.64
SLK Q9H2G2 2/20 0.64
CARS1 P49589 1/20 0.64
ERBB2 P04626 3/20 0.62
ABCG2 Q9UNQ0 2/20 0.62
ERBB4 Q15303 2/20 0.62
AURKA O14965 2/20 0.62
KDR P35968 2/20 0.62
PLK4 O00444 1/20 0.62
CIT O14578 1/20 0.62
EPHB6 O15197 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7665701 0.99 EGFR (0.67) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL29894409 0.85 ABCG2 (0.76) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL183355 0.85 ABCG2 (0.76) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL29484155 0.85 EGFR (0.69) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL256396 0.85 EGFR (0.69) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL28407487 0.85 EGFR (0.69) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL2607975 0.85 EGFR (0.72) EGFRFBP1GAKALDH1A1MAPT
Hydrochloric Acid SCHEMBL3873473 0.84 EGFR (0.67) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL1507464 0.82 EGFR (0.70) EGFRFBP1GAKALDH1A1MAPT
SCHEMBL1507562 0.82 EGFR (0.67) EGFRFBP1GAKALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0907642-A1 PHENYLAMINO-SUBSTITUTED TRICYCLIC DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES PFIZER INC. (US) 1999-04-14 EP claimed
WO-1997049688-A1 PHENYLAMINO-SUBSTITUTED TRICYCLIC DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES PFIZER INC. (US) 1997-12-31 WO claimed
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
US-6335344-B1 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases PFIZER INC. 2002-01-01 US disclosed
EP-0907642-A1 PHENYLAMINO-SUBSTITUTED TRICYCLIC DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES PFIZER INC. (US) 1999-04-14 EP disclosed
WO-1997049688-A1 PHENYLAMINO-SUBSTITUTED TRICYCLIC DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES PFIZER INC. (US) 1997-12-31 WO disclosed